298 related articles for article (PubMed ID: 11654294)
1. Toward achieving meaningful informed consent in AIDS vaccine trials with injection-drug users.
Sugarman J
AIDS Public Policy J; 1994; 9(4):167-72. PubMed ID: 11654294
[No Abstract] [Full Text] [Related]
2. Toward an informed discussion of informed consent: a review and critique of the empirical studies.
Meisel A; Roth LH
Ariz Law Rev; 1983; 25(2):265-346. PubMed ID: 11658677
[No Abstract] [Full Text] [Related]
3. Enhancing comprehension of information for informed consent: a review of empirical research.
Silva MC; Sorrell JM
IRB; 1988; 10(1):1-5. PubMed ID: 11658988
[No Abstract] [Full Text] [Related]
4. Protocol review within the context of a research program.
Miller FG; Rosenstein DL
IRB; 1998; 20(4):7-10. PubMed ID: 11657088
[No Abstract] [Full Text] [Related]
5. Endings of clinical research protocols: distinguishing therapy from research.
Grinnell F
IRB; 1990; 12(4):1-3. PubMed ID: 11651260
[No Abstract] [Full Text] [Related]
6. AIDS prevention among IV drug users: potential conflicts between research design and ethics.
Des Jarlais DC; Friedman SR
IRB; 1987; 9(1):6-8. PubMed ID: 11649891
[No Abstract] [Full Text] [Related]
7. Estimating risks and benefits in AIDS vaccine and drug trials.
Kessel E
AIDS Public Policy J; 1990; 5(4):186-8. PubMed ID: 11650977
[No Abstract] [Full Text] [Related]
8. Facilitating ethical research: promoting informed choice.
National Council on Bioethics in Human Research (Canada)
NCBHR Commun; 1996 Dec; 7(2 Suppl):i-1-28. PubMed ID: 11660531
[No Abstract] [Full Text] [Related]
9. Patients' competence to consent to neurobiological research.
Appelbaum PS
Account Res; 1996; 4(3-4):241-51. PubMed ID: 11654519
[No Abstract] [Full Text] [Related]
10. Pharmacological and psychological research on AIDS: some ethical considerations.
Perry SW
IRB; 1987; 9(5):8-10. PubMed ID: 11649899
[No Abstract] [Full Text] [Related]
11. Ethical considerations in AIDS vaccine testing.
Porter JP; Glass MJ; Koff WC
IRB; 1989; 11(3):1-4. PubMed ID: 11650206
[No Abstract] [Full Text] [Related]
12. What kinds of subjects can understand this protocol?
Levine RJ
IRB; 1984; 6(5):6-8. PubMed ID: 11650664
[No Abstract] [Full Text] [Related]
13. Shaking up the status quo: how AIDS activists have challenged drug development and approval procedures.
Dunbar MM
Food Drug Cosmet Law J; 1991 Sep; 46(5):673-706. PubMed ID: 11651380
[No Abstract] [Full Text] [Related]
14. Some ethical issues associated with HIV vaccine trials.
Novick A
AIDS Public Policy J; 1988; 3(3):46-8. PubMed ID: 11650102
[No Abstract] [Full Text] [Related]
15. The importance of maintaining patient's continued and informed consent.
Kaminski R
J Calif Alliance Ment Ill; 1994; 5(1):57-8. PubMed ID: 11653326
[No Abstract] [Full Text] [Related]
16. Rate of refusal to participate in clinical trials.
Shimm DS; Spece RG
IRB; 1992; 14(2):7-9. PubMed ID: 11651246
[No Abstract] [Full Text] [Related]
17. Playing roulette with experimental drugs.
Budiansky S
US News World Rep; 1987 Jul; 103(2):58-9. PubMed ID: 11658841
[No Abstract] [Full Text] [Related]
18. Equipoise and the problem of research subjects with diminished capacity.
Kahn J
Account Res; 1999; 7(2-4):277-82. PubMed ID: 11658182
[No Abstract] [Full Text] [Related]
19. Informed consent in psychiatric research.
Roth LH; Appelbaum PS; Lidz CW; Benson P; Winslade WJ
Rutgers Law Rev; 1987; 39(2-3):425-41. PubMed ID: 11659013
[No Abstract] [Full Text] [Related]
20. Controversial legal consent in clinical medicine.
Chafe SM
Ann R Coll Physicians Surg Can; 1992 Apr; 25(2):109-11. PubMed ID: 11651257
[No Abstract] [Full Text] [Related]
[Next] [New Search]
